|
Volumn 58, Issue 2, 2003, Pages 127-131
|
Relative bioavailability study of two formulations of chlormadinone acetate: Luteran® 5mg and Luteran® tablet dosed at 10mg;Etude de la biodisponibilité relative de deux formulations orales d'acétate de chlormadinone: Lutéran® 5 mg et Luteran® comprimé dosé à 10 mg
|
Author keywords
Chlormadinone acetate; Relative bioavailability
|
Indexed keywords
CHLORMADINONE ACETATE;
ABDOMINAL PAIN;
AREA UNDER THE CURVE;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DIARRHEA;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG FORMULATION;
GAS CHROMATOGRAPHY;
HUMAN;
HYPOGLYCEMIA;
MASS SPECTROMETRY;
NAUSEA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
|
EID: 0042155308
PISSN: 00405957
EISSN: None
Source Type: Journal
DOI: 10.2515/therapie:2003018 Document Type: Article |
Times cited : (5)
|
References (8)
|